COMPUTEX-TAIPEI
8.2.2021 07:17:09 CET | Business Wire | Press release
Asia’s largest ICT show, COMPUTEX Taipei, is rolling out its first in Online-Merge-Offline (OMO) hybrid exhibition this year. COMPUTEX 2021 Hybrid combines the onsite exhibition with #COMPUTEXVirtual for an exceptionally vibrant, accessible, comprehensive show and customer experience. In addition, #InnoVEXVirtual will be held on a parallel track. Through the virtual experiences, COMPUTEX aims to help industry leaders and startup companies get the best exhibition performance results and greatest value.
COMPUTEX onsite Exhibition
The onsite COMPUTEX will take place at the Taipei Nangang Exhibition Center, Hall 1 & 2, from June 1-4. This year’s exhibition will revolve around seven major themes: 5G, AI & IoT, Edge Computing, High-Performance Computing (HPC), Cyber Security, Gaming, and Innovations & Startups. These themes showcase Taiwan’s historical and future supply chain dominance throughout the global ICT industry.
InnoVEX will debut at Taipei Nangang Exhibition Center, Hall 1 (TaiNEX 1) as a global startup stage to display inventions that stand to reshape the technology landscape worldwide.
#COMPUTEXVirtual Online Exhibition
#COMPUTEXVirtual will take place from May 31-June 30 online with #InnoVEXVirtual as a part of the online show. Together, the online exhibition will highlight the following four features:
- Tech Insights:
COMPUTEX Forum, InnoVEX Forum, keynote speeches from leading companies, live demonstrations and related webinars will be available via live-streaming. These resources will reveal the latest technology trends with insights into what’s next for the tech industry.
- Virtual Display:
Exhibitors will showcase their products at virtual booths via videos and images. Provided contact information allows exhibitors to seize every opportunity to generate leads without the hindrance of any time differences.
- Matchmaking and Networking:
Video conferencing, meeting requests and instant messaging make it possible to break down barriers across countries and establish the most effective, timely communication channels for exhibitors and buyers.
- Hyper-Personalized Recommendation:
#COMPUTEXVirtual will use AI technology to identify user behaviors and provide interesting marketing strategies to exhibitors. Hyper-Personalized Recommendations will help increase the matchmaking accuracy and shape brand perception.
COMPUTEX Hybrid Webinars to be held on March 3.
#COMPUTEXVirtual and #InnoVEXVirtual are now open for registration. To demonstrate how the online events leverage cutting-edge technologies to overcome time and geographical limitations, the event organizer, Taiwan External Trade Development Council, will hold international webinars on March 3.
- #COMPUTEXVirtual exhibitor registration:
https://events.taiwantrade.com/CVirtual01
- #InnoVEXVirtual exhibitor registration:
https://events.taiwantrade.com/IVirtual01
- COMPUTEX Hybrid Webinars:
https://events.taiwantrade.com/CVirtual02
For more update：
COMPUTEX website: https://www.computextaipei.com.tw/
InnoVEX website: https://www.innovex.com.tw/
About COMPUTEX TAIPEI (also called COMPUTEX):
Established in 1981, COMPUTEX is one of the leading global ICT, IoT, and startup tradeshows with a complete supply chain and IoT ecosystems. Co-organized by the Taiwan External Trade Development Council (TAITRA) and Taipei Computer Association (TCA), COMPUTEX, based upon Taiwan’s complete ICT clusters, covers the whole spectrum of the ICT industry, from established brands to startups and from ICT supply chain to IoT ecosystems. With strong R&D and manufacturing capabilities and IPR protection, Taiwan is a strategic destination for foreign companies and investors looking for partners in global technology ecosystems. Follow COMPUTEX on its website at www.computextaipei.com.tw and Twitter @computex_taipei using the hashtag #COMPUTEX.
About TAITRA:
Founded in 1970, TAITRA is Taiwan's foremost nonprofit trade promoting organization. Sponsored by the government and industry organizations, TAITRA assists enterprises to expand their global reach. Headquartered in Taipei, TAITRA has a team of 1,300 specialists and operates 5 local offices in Taoyuan, Hsinchu, Taichung, Tainan and Kaohsiung, as well as 63 branches worldwide. Together with Taipei World Trade Center (TWTC) and Taiwan Trade Center (TTC), TAITRA has formed a global network dedicated to promoting world trade.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210207005039/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States1.7.2026 07:00:00 CEST | Press release
Galderma received a Complete Response Letter from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization Relfydess is approved in 33 markets and already launched in more than 20, including across Europe, the Middle East and Australia, with an encouraging early launch trajectory supported by positive healthcare professional feedback Regulatory filings in other territories are ongoing and remain on track Ad hoc announcement pursuant to Art. 53 LR Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“FDA”). The Company has received a Complete Response Letter (CRL) from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization. As part of its review, the FDA conducted a Pre-License Inspection (PLI) of Galderma’s manufa
EVE Energy Showcases All-Scenario Energy Storage Solutions at The Smarter E Europe 20261.7.2026 03:45:00 CEST | Press release
EVE Energy unveiled its Mr. Big Family series, a 6.9+ MWh energy storage system, and all-scenario energy storage solutions at Intersolar Europe in Munich. Drawing on traceable large-cell technology, proven large-scale energy storage project delivery experience, and global delivery capabilities, the company is addressing Europe's diverse energy storage requirements across utility-scale, commercial & industrial (C&I ), and data center segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630889717/en/ EVE Energy showcases its Mr. Giant 3.0 6.9+ MWh energy storage system at The Smarter E Europe 2026 in Munich, Germany Advancing Large-Cell Technology with Global Project Validation As one of the first companies to focus on large-capacity energy storage cells, EVE Energy has iteratively upgraded its cell platform from 560 Ah and 628 Ah to 702 Ah, adhering to a stacking process route throughout. At the exhibition, the Mr. Gia
Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 01:56:00 CEST | Press release
Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom